We have recently developed a simple method to investigate the colonic response to food (CRF). This study describes the modifications of CRF induced by treatment with oral pinaverium bromide in irritable bowel syndrome (IBS) patients. Thirty healthy subjects and 43 patients suffering from IBS were studied. Colonic transit time (CTT) was measured in fasting conditions and after eating a standard test meal. Colonic response to food was quantified by calculating the variation in number of markers in each zone of interest of the large bowel between the X-ray films of the abdomen taken before and after eating. CRF is characterized by caudal propulsion of colonic contents in the two groups. In controls, there is emptying of the caecum-ascending colon region and filling of the rectosigmoid. In IBS patients, only the left transverse colon and the splenic flexure empty. Pinaverium bromide exerts no effect in controls but reverses the CRF of the right colon in IBS patients by inhibiting right colon emptying. These results suggest that the inhibitory action of pinaverium bromide on CRF may support the clinical efficacy of this calcium channel blocker in the treatment of IBS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0753-3322(01)80005-6 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Repurposing pinaverium bromide against Staphylococcus and its biofilms with new mechanisms.
AMB Express
December 2024
Department of Laboratory Medicine, The Affiliated Changsha Hospital of Xiangya School of Medicine (The First Hospital of Changsha), Central South University, No. 311, Yingpan Road, Changsha, 410005, Hunan, China.
Antibiotic resistance by methicillin-resistant Staphylococcus aureus (MRSA) is an urgent threat to human health. The biofilm and persister cells formation ability of MRSA and Staphylococcus epidermidis often companied with extremely high antimicrobial resistance. Pinaverium bromide (PVB) is an antispasmodic compound mainly used for irritable bowel syndrome.
View Article and Find Full Text PDFA platform of functional studies of ESCC-associated gene mutations identifies the roles of TGFBR2 in ESCC progression and metastasis.
Cell Rep
November 2024
Department of Gastroenterology, State Key Laboratory of Biotherapy and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Frontiers Medical Center, Tianfu Jincheng Laboratory, No387-201 Hemin st., Chengdu, Sichuan 610212, China; Children's Medicine Key Laboratory of Sichuan Province, Sichuan 610041, China. Electronic address:
Genomics studies have detected numerous genetic alterations in esophageal squamous cell carcinoma (ESCC). However, the functions of these mutations largely remain elusive, partially due to a lack of feasible animal models. Here, we report a convenient platform with CRISPR-Cas9-mediated introduction of genetic alterations and orthotopic transplantation to generate a series of primary ESCC models in mice.
View Article and Find Full Text PDFThe structure of pinaverium bromide (systematic name: 4-[(2-bromo-4,5-di-meth-oxy-phen-yl)meth-yl]-4-{2-[2-(6,6-dimethyl-2-bi-cyclo-[3.1.1]hepta-nyl)eth-oxy]eth-yl}morpholin-4-ium bromide; CHBrNO), was determined at 110 K.
View Article and Find Full Text PDFAcute exposure and biomarkers assessment in rainbow trout exposed to selected pharmaceuticals.
Environ Toxicol Pharmacol
June 2024
Aquatic Contaminants Research Division, Environment and Climate Change Canada, 105 McGill, Montréal, Québec H2Y 2E7, Canada. Electronic address:
Article Synopsis
- Pharmaceuticals in municipal wastewater can harm aquatic life, particularly rainbow trout.
- Five drugs—olanzapine, erythromycin, mycophenoate, pinaverium, and trazodone—were tested for toxicity, with olanzapine showing the highest lethality.
- Factors like drug mass, pKa, and hydrophobicity influence toxicity, with certain characteristics leading to greater harm, including effects on metabolic activity and DNA damage in fish.
Efficacy and safety of pinaverium bromide as an add-on therapy in refractory dyspepsia: A randomized controlled trial.
JGH Open
March 2024
Department of Radiology, Faculty of Medicine Chiang Mai University Chiang Mai Thailand.
Background And Aim: Functional dyspepsia (FD) remains a therapeutic challenge, and the efficacy of antispasmodic agents as adjunctive therapy is not well established. This study aimed to evaluate the efficacy and safety of pinaverium bromide added to omeprazole in treating refractory FD.
Methods: We conducted a randomized, placebo-controlled trial in patients with refractory dyspepsia.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!